Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ovarian Neoplasms

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 32 articles: HTML format Text format

Single Articles

January 2019
1. SHEN W, Niu N, Lawson B, Qi L, et al
   GATA6: a new predictor for prognosis in ovarian Cancer.
   Hum Pathol. 2019 Jan 8. pii: S0046-8177(19)30003.
   PubMed     Text format     Abstract available
   
   
   November 2018
2. SEHOULI J, Braicu EI, Richter R, Denkert C, et al
   Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network.
   Hum Pathol. 2018 Nov 11. pii: S0046-8177(18)30417.
   PubMed     Text format     Abstract available
   
   
   August 2018
3. WANG J, Gao H, Liu G, Gu L, et al
   Tumor necrosis factor alpha-induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapy.
   Hum Pathol. 2018 Aug 11. pii: S0046-8177(18)30301.
   PubMed     Text format     Abstract available
   
   
   March 2018
4. HUI P, Gysler SM, Uduman M, Togun TA, et al
   MicroRNA Signatures Discriminate Between Uterine and Ovarian Serous Carcinomas.
   Hum Pathol. 2018 Mar 5. pii: S0046-8177(18)30070.
   PubMed     Text format     Abstract available
   
   
   
5. ROY M, Connor J, Al-Niaimi A, Rose SL, et al
   Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
   Hum Pathol. 2018;73:1-6.
   PubMed     Text format     Abstract available
   
   
   February 2018
6. XING D, Banet N, Sharma R, Vang R, et al
   Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
   Hum Pathol. 2018;72:160-166.
   PubMed     Text format     Abstract available
   
   
   December 2017
7. OJALVO LS, Thompson ED, Wang TL, Meeker AK, et al
   Tumor-Associated Macrophages and the Tumor Immune Microenvironment of Primary and Recurrent Epithelial Ovarian Cancer (EOC).
   Hum Pathol. 2017 Dec 26. pii: S0046-8177(17)30478.
   PubMed     Text format     Abstract available
   
   
   November 2017
8. ESPINOSA I, De Leo A, D'Angelo E, Rosa-Rosa JM, et al
   Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
   Hum Pathol. 2017 Nov 10. pii: S0046-8177(17)30413.
   PubMed     Text format     Abstract available
   
   
   October 2017
9. ARTS FA, Keogh L, Smyth P, O'Toole S, et al
   miR-223 potentially targets SWI/SNF complex protein SMARCD1 in Atypical Proliferative Serous Tumor and High Grade Ovarian Serous Carcinoma.
   Hum Pathol. 2017 Oct 24. pii: S0046-8177(17)30377.
   PubMed     Text format     Abstract available
   
   
   
10. ESPINOSA I, D'Angelo E, Corominas M, Gonzalez A, et al
    Mixed Endometrial Carcinomas with a "Low-Grade Serous"-Like Component: a Clinicopathologic, Immunohistochemical, and Molecular Genetic Study.
    Hum Pathol. 2017 Oct 24. pii: S0046-8177(17)30385.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. XING D, Rahmanto YS, Zeppernick F, Hannibal CG, et al
    Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.
    Hum Pathol. 2017 Sep 2. pii: S0046-8177(17)30303.
    PubMed     Text format     Abstract available
    
    
    July 2017
12. RUSSO M, Broach J, Sheldon K, Houser KR, et al
    Clonal Evolution in Paired Endometrial Intraepithelial Neoplasia/Atypical Hyperplasia and Endometrioid Adenocarcinoma.
    Hum Pathol. 2017 Jul 13. pii: S0046-8177(17)30244.
    PubMed     Text format     Abstract available
    
    
    
13. SCHOOLMEESTER JK, Moyer AM, Goodenberger ML, Keeney GL, et al
    Pathologic Findings in Breast, Fallopian Tube and Ovary Specimens in non-BRCA Hereditary Breast and/or Ovarian Cancer Syndromes: A Study of 18 Patients with Deleterious Germline Mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH or CHEK2.
    Hum Pathol. 2017 Jul 11. pii: S0046-8177(17)30240.
    PubMed     Text format     Abstract available
    
    
    April 2017
14. ROTH LM, Lyu B, Cheng L
    Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
    Hum Pathol. 2017 Apr 23. pii: S0046-8177(17)30125.
    PubMed     Text format     Abstract available
    
    
    
15. AMAN M, Ohishi Y, Imamura H, Shinozaki T, et al
    Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
    Hum Pathol. 2017 Apr 21. pii: S0046-8177(17)30123.
    PubMed     Text format     Abstract available
    
    
    
16. WANG WC, Lai YC
    Mature cystic teratomas of the ovary-reply.
    Hum Pathol. 2017 Apr 20. pii: S0046-8177(17)30118.
    PubMed     Text format    
    
    
    
17. YAMASHITA Y
    Mature cystic teratomas of the ovary.
    Hum Pathol. 2017 Apr 18. pii: S0046-8177(17)30115.
    PubMed     Text format    
    
    
    
18. KIM WY, Shim SH, Jung HY, Dong M, et al
    The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Hum Pathol. 2017 Apr 17. pii: S0046-8177(17)30108.
    PubMed     Text format     Abstract available
    
    
    
19. TAUBE ET, Denkert C, Sehouli J, Unger U, et al
    Cytokeratin 5/6 expression, prognosis and association with ER-alpha in high-grade serous ovarian carcinoma.
    Hum Pathol. 2017 Apr 13. pii: S0046-8177(17)30105.
    PubMed     Text format     Abstract available
    
    
    
20. HAREL-DASSA K, Yedgar S, Trope CG, Davidson B, et al
    Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.
    Hum Pathol. 2017;62:115-121.
    PubMed     Text format     Abstract available
    
    
    February 2017
21. RAWISH KR, Desouki MM, Fadare O
    Atypical Mucinous Glandular Proliferations in Endometrial Samplings: Follow-Up and Other Clinicopathologic Findings In 41 cases.
    Hum Pathol. 2017 Feb 20. pii: S0046-8177(17)30048.
    PubMed     Text format     Abstract available
    
    
    
22. BRONER EC, Trope CG, Reich R, Davidson B, et al
    TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
    Hum Pathol. 2017;60:180-187.
    PubMed     Text format     Abstract available
    
    
    December 2016
23. ROSSI ED, Bizzarro T, Monterossi G, Inzani F, et al
    Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.
    Hum Pathol. 2016 Dec 29. pii: S0046-8177(16)30357.
    PubMed     Text format     Abstract available
    
    
    November 2016
24. PELLETIER MP, Trinh VQ, Stephenson P, Mes-Masson AM, et al
    Microcystic, elongated and fragmented (MELF) pattern invasion is mainly associated with isolated tumor cell pattern metastases in FIGO grade I endometrioid endometrial cancer (EEC).
    Hum Pathol. 2016 Nov 15. pii: S0046-8177(16)30306.
    PubMed     Text format     Abstract available
    
    
    
25. WANG Y, Li M, Meng F, Lou G, et al
    HPIP Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with epithelial ovarian cancer.
    Hum Pathol. 2016 Nov 3. pii: S0046-8177(16)30286.
    PubMed     Text format     Abstract available
    
    
    October 2016
26. ZHANG C, Sung CJ, Quddus MR, Simon RA, et al
    Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: A clinicopathologic study of 238 cases.
    Hum Pathol. 2016 Oct 13. pii: S0046-8177(16)30245.
    PubMed     Text format     Abstract available
    
    
    September 2016
27. KATO N, Kusumi T, Kamataki A, Tsunoda R, et al
    DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: A potential association with androgenic effects.
    Hum Pathol. 2016 Sep 21. pii: S0046-8177(16)30213.
    PubMed     Text format     Abstract available
    
    
    
28. SCHOLZ B, Beckert M, Mordstein V, Hohmann N, et al
    Seromucinous borderline tumor of the testis-a case report.
    Hum Pathol. 2016 Sep 2. pii: S0046-8177(16)30206.
    PubMed     Text format     Abstract available
    
    
    June 2016
29. LIANG L, Jiang Y, Chen JS, Niu N, et al
    B7-H4 Expression in Ovarian Serous Carcinoma: A Study of 306 Cases.
    Hum Pathol. 2016 Jun 24. pii: S0046-8177(16)30129.
    PubMed     Text format     Abstract available
    
    
    
30. PASCUAL-GARCIA M, Bertolo C, Nieto JC, Serrat N, et al
    CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.
    Hum Pathol. 2016 Jun 23. pii: S0046-8177(16)30124.
    PubMed     Text format     Abstract available
    
    
    
31. WANG WC, Lai YC
    Genetic analysis results of mature cystic teratomas of the ovary in Taiwan disagree with the previous origin theory of this tumor.
    Hum Pathol. 2016;52:128-35.
    PubMed     Text format     Abstract available
    
    
    March 2016
32. MANDATO VD, Aguzzoli L, Costagliola L, Abrate M, et al
    Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.
    Hum Pathol. 2016 Mar 4. pii: S0046-8177(16)00073.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: